Evaluation of Microcirculation With Photoplethysmography (Pulse Oximetry) in Healthy Volunteers and Ventilated Patients
1 other identifier
observational
20
1 country
1
Brief Summary
The objective of this observational study is to explore microcirculation in healthy volunteers and in ventilated patients in the operating room and in critical care. The general objective of this study is to evaluate microcirculation with photoplethysmography (PPG) in different pathophysiological situations and to compare PPG with available standard methods. Specifically, evaluate the correlation between the determinations of AC-DC waves obtained by Photoplethysmography (PPG) and those obtained in different dynamic tests in healthy volunteers. To compare microcirculation assessments \[capillary refill time (CRT), perfusion index (PI), perfusion index variability (PIV)\] with measurements obtained by PPG in the context of critically ill patients. To compare microcirculation assessments (CRT, PI PVI) with measurements obtained by PPG in the context of patients on invasive mechanical ventilation (IMV) in the operating room and in critical care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 19, 2023
CompletedFirst Submitted
Initial submission to the registry
November 10, 2023
CompletedFirst Posted
Study publicly available on registry
November 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedNovember 24, 2023
November 1, 2023
2 years
November 10, 2023
November 21, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
variations in AC signal of photoplethysmography
Changes in the AC wave of photoplethysmography (it does not currently have standardized measurement units) will be evaluated in each functional test (CRT, LPR, venous occlusion test, progressive arterial occlusion test). It will be treated as a continuous numerical variable.
Through study completion, an average of 1 year
variations in DC signal of photoplethysmography
Changes in the DC wave of photoplethysmography (it does not currently have standardized measurement units) will be evaluated in each functional test (CRT, LPR, venous occlusion test, progressive arterial occlusion test). It will be treated as a continuous numerical variable.
Through study completion, an average of 1 year
Study Arms (3)
Healthy volunteers
\>18 years old healthy
Patients in critical care unit
patient in ICU with requirement for hemodynamic monitoring
Patients with ventilatory support in the operating room or critical care unit
patient in the ICU or operating room with a requirement for hemodynamic monitoring and ventilatory support
Interventions
Photoplethysmography (BluePoint, Frankfurt, Germany) is the pulse wave measured by a pulse oximeter. It is obtained based on the absorbance of red/infrared light in a given tissue. The signal is made up of two components: 1) the alternating component (AC), which is the pulse wave itself, which is determined by the absorbance of pulsatile arterial blood. 2) The continuous component (DC), which represents the absorbance of venous blood and the rest of the tissues. Within these tests the investigators find vascular occlusion, elevation of the legs, raising or lowering the tested hand above/below the phlebostatic level, cold/heat test, etc. Each of them evaluates different aspects of circulation such as endothelial function, myogenic response to blood flow, perfusion pressure, autonomic reflexes, preload-dependence, or venous flow among other aspects of microcirculation.
Eligibility Criteria
healthy volunteers or operating room or intensive care patients- See inclusion and exclusion criteria
You may qualify if:
- Written informed consent.
- Age \> 18 years.
You may not qualify if:
- Pregnancy.
- Smokers.
- Respiratory and/or cardiovascular pathologies.
- Peripheral vascular disease.
- Operation room or Critical care Unit patients
- Written informed consent.
- Age \> 18 years.
- Critical patients ventilated in the ICU of any origin.
- Known peripheral vascular disease.
- Burns on both upper limbs.
- Trauma to both upper limbs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Privado de Comunidad
Mar del Plata, Buenos Aires, 7600, Argentina
Study Officials
- PRINCIPAL INVESTIGATOR
Nora Fuentes, PhD
Hospital Privado de Comunidad
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 10, 2023
First Posted
November 21, 2023
Study Start
June 19, 2023
Primary Completion
June 1, 2025
Study Completion
June 1, 2025
Last Updated
November 24, 2023
Record last verified: 2023-11